Radiotherapy to Enhance Chimeric Antigen Receptor T-Cell Therapeutic Efficacy in Solid Tumours

Narrative review discusses the current developments in chimeric antigen receptor (CAR) T-cell therapy and the opportunities and challenges in combining CAR T-cell therapy with radiotherapy, which may provide a strategy to prevent resistance to CAR T-cell therapy of solid tumours.

Source:

JAMA Oncology